CU20190083A7 - Método mejorado para la producción de altos niveles de crm197 - Google Patents

Método mejorado para la producción de altos niveles de crm197

Info

Publication number
CU20190083A7
CU20190083A7 CU2019000083A CU20190083A CU20190083A7 CU 20190083 A7 CU20190083 A7 CU 20190083A7 CU 2019000083 A CU2019000083 A CU 2019000083A CU 20190083 A CU20190083 A CU 20190083A CU 20190083 A7 CU20190083 A7 CU 20190083A7
Authority
CU
Cuba
Prior art keywords
sub
improved method
crm197
high level
level production
Prior art date
Application number
CU2019000083A
Other languages
English (en)
Other versions
CU24668B1 (es
Inventor
Deviprasanna Chakka
Mahima Datla
Mandar Shirish Dixit
Narender Dev Mantena
Balamurali Masilamani
Ramesh Venkat Matur
Rajan Sriraman
Satyam Naidu Sureddi
Original Assignee
Biological E Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological E Ltd filed Critical Biological E Ltd
Publication of CU20190083A7 publication Critical patent/CU20190083A7/es
Publication of CU24668B1 publication Critical patent/CU24668B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1077—Pentosyltransferases (2.4.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacture Of Electron Tubes, Discharge Lamp Vessels, Lead-In Wires, And The Like (AREA)
  • Forging (AREA)
  • Peptides Or Proteins (AREA)

Abstract

<p>La presente invención proporciona un método mejorado para la producción de CRM<sub>197</sub> con alto rendimiento mediante el uso de la cepa de Corynebacterium diphtheria modificada genéticamente que tiene un número incrementado de copias del gen de CRM<sub>197</sub>, en donde el método comprende crecer la cepa en un medio libre de componentes derivados de animales con uno o más aminoácidos.</p>
CU2019000083A 2017-04-22 2018-04-19 Método para la producción de alto nivel de crm197 a partir de una cepa genéticamente modificada de corynebacterium diphtheriae CU24668B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741014335 2017-04-22
PCT/IN2018/050235 WO2018193475A2 (en) 2017-04-22 2018-04-19 An improved method for high level production of crm

Publications (2)

Publication Number Publication Date
CU20190083A7 true CU20190083A7 (es) 2020-10-20
CU24668B1 CU24668B1 (es) 2023-07-12

Family

ID=63678648

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2019000083A CU24668B1 (es) 2017-04-22 2018-04-19 Método para la producción de alto nivel de crm197 a partir de una cepa genéticamente modificada de corynebacterium diphtheriae

Country Status (30)

Country Link
US (1) US11098089B2 (es)
EP (1) EP3612553B1 (es)
JP (1) JP7161493B2 (es)
KR (1) KR102637436B1 (es)
CN (1) CN110741013B (es)
AU (1) AU2018255959B2 (es)
BR (1) BR112019022093A2 (es)
CA (1) CA3060723A1 (es)
CL (1) CL2019003003A1 (es)
CO (1) CO2019011643A2 (es)
CU (1) CU24668B1 (es)
DK (1) DK3612553T3 (es)
EA (1) EA201992527A1 (es)
ES (1) ES2926535T3 (es)
HR (1) HRP20221060T1 (es)
HU (1) HUE059629T2 (es)
IL (1) IL270075B1 (es)
LT (1) LT3612553T (es)
MX (1) MX2019012563A (es)
MY (1) MY194242A (es)
PH (1) PH12019550214A1 (es)
PL (1) PL3612553T3 (es)
PT (1) PT3612553T (es)
RS (1) RS63551B1 (es)
SA (1) SA519410306B1 (es)
SG (1) SG11201909765XA (es)
SI (1) SI3612553T1 (es)
UA (1) UA127497C2 (es)
WO (1) WO2018193475A2 (es)
ZA (1) ZA201906270B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755380A (zh) * 2021-09-23 2021-12-07 艾美卫信生物药业（浙江）有限公司 一种发酵生产白喉毒素crm197蛋白的菌种培养基、配制方法以及菌种复苏培养方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434079T2 (de) * 1993-03-05 2005-02-24 Wyeth Holdings Corp. Plasmid zur Herstellung von CRM-Protein und Diphtherie-Toxin
US20040087020A1 (en) * 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
EP2199382A3 (en) 1997-05-28 2010-09-22 Novartis Vaccines and Diagnostics S.r.l. Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
GB9904582D0 (en) 1999-02-26 1999-04-21 Nycomed Imaging As Process
EP1692269A4 (en) * 2003-12-12 2007-09-26 Sanofi Pasteur Ltd PRODUCTION OF DIPHTHERIA TOXIN
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
AU2010201410B2 (en) * 2010-03-30 2015-04-30 Pelican Technology Holdings, Inc. High level expression of recombinant CRM197
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
FR2992656B1 (fr) * 2012-07-02 2016-10-07 Sanofi Pasteur Procede de production d'antigenes haemophilus influenzae type b
ITMI20130142A1 (it) * 2013-01-31 2014-08-01 Biosynth Srl Vaccini glicoconiugati comprendenti unita' di base di un costrutto molecolare esprimente epitopi multipli incorporati
JP6473460B2 (ja) * 2014-03-03 2019-02-20 スカラブ ゲノミクス， エルエルシー 大腸菌における組換えｃｒｍ１９７の産生強化

Also Published As

Publication number Publication date
PH12019550214A1 (en) 2020-09-14
AU2018255959B2 (en) 2022-02-17
EA201992527A1 (ru) 2020-02-28
BR112019022093A2 (pt) 2020-05-05
CA3060723A1 (en) 2018-10-25
SG11201909765XA (en) 2019-11-28
WO2018193475A3 (en) 2018-12-27
CU24668B1 (es) 2023-07-12
SA519410306B1 (ar) 2022-02-02
CN110741013A (zh) 2020-01-31
KR20200010218A (ko) 2020-01-30
EP3612553A2 (en) 2020-02-26
IL270075B1 (en) 2024-02-01
UA127497C2 (uk) 2023-09-13
RS63551B1 (sr) 2022-09-30
PT3612553T (pt) 2022-09-08
AU2018255959A1 (en) 2019-11-14
WO2018193475A2 (en) 2018-10-25
ES2926535T3 (es) 2022-10-26
MX2019012563A (es) 2019-12-02
CL2019003003A1 (es) 2020-02-14
MY194242A (en) 2022-11-24
PL3612553T3 (pl) 2022-11-07
JP7161493B2 (ja) 2022-10-26
CO2019011643A2 (es) 2020-01-17
AU2018255959A8 (en) 2022-02-17
CN110741013B (zh) 2023-08-08
US20200277341A1 (en) 2020-09-03
EP3612553B1 (en) 2022-06-08
HUE059629T2 (hu) 2022-12-28
LT3612553T (lt) 2022-09-26
DK3612553T3 (da) 2022-08-29
SI3612553T1 (sl) 2022-11-30
IL270075A (es) 2019-12-31
ZA201906270B (en) 2020-07-29
US11098089B2 (en) 2021-08-24
HRP20221060T1 (hr) 2022-11-11
KR102637436B1 (ko) 2024-02-15
JP2020517274A (ja) 2020-06-18

Similar Documents

Publication Publication Date Title
CO2020015314A2 (es) Composiciones de arni contra el angiotensinógeno (agt) y métodos para su uso
CR20140538A (es) Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
AR086470A1 (es) Metodo implementado por un dispositivo de computacion y aparatos que utilizan tecnicas de canales de color y marcadores opticos
BR112018077358A2 (pt) tagatose-6-fosfato fosfatase termoestável inovadora e um método para produzir tagatose com o uso da mesma
CY1123840T1 (el) Οξινη συνθεση με βαση λεοναρδιτη και αμινοξεα
CR20190397A (es) Método para producir anticuerpos multiespecíficos
BR112016028252A2 (pt) cambota para suporte e consolidação de uma escavação e método para instalação de uma estrutura para suporte e consolidação de uma escavação
ES2634683T3 (es) Método de preparación de cisteína o de un derivado de la misma utilizando una nueva O-fosfoserina sulfhidrilasa
MX2016012179A (es) Composiciones acrílicas curadas en doble etapa y métodos relacionados.
CU20190083A7 (es) Método mejorado para la producción de altos niveles de crm197
CL2022001673A1 (es) Anticuerpos contra la integrina alfa 11 beta 1.
BR112017005430A2 (pt) um polímero orgânico curável que compreende pelo menos uma unidade de acilureia, sua preparação e uso.
PE20170941A1 (es) Genes de tolerancia a herbicidas y metodos para usar los mismos
BR112019004109A2 (pt) sistema para levantamento sísmico marinho
AR114072A1 (es) Plantas con genes dhs modificados
CO2023015915A2 (es) Anticuerpos anti-ccr8
CL2021000629A1 (es) Microorganismo para la producción de l-aminoácido con actividad mejorada de a-glucosidasa y procedimiento para la producción de l-aminoácido usando el mismo
BR112018017227A2 (pt) método para produzir um l-aminoácido
CO2021004915A2 (es) Método para la producción de ácido acrílico o sus sales
BR112016019179A2 (pt) aminoácido de ciclopropenos e métodos
BR112018008045A2 (pt) micro-organismo recombinante que produz l-treonina e um método para produzir l-treonina com o uso do mesmo
BR112021025181A2 (pt) Método para biotransformação de tricotecenos
BR112021020037A2 (pt) Polipeptídeos enpp1 e métodos para o uso dos mesmos
MX2018000502A (es) Mejora del metabolismo de microalga de xilosa.